⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XENE News
Xenon Pharmaceuticals Inc
Xenon to Present at Wells Fargo Healthcare Conference
globenewswire.com
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XENE
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026
globenewswire.com
XENE
Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight
globenewswire.com
BIIB
HRMY
XNCR
AZN
LLY
PFE
REGN
NVS
TSLA
TAK
GSK
JNJ
UCB
BHF
PRAX
XENE
AQST
TNDM
INCY
MRK
ABBV
BMY
AMGN
GILD
VRTX
CRSP
EDIT
NTLA
SRPT
ALNY
EXAS
TEVA
AXSM
CYTK
INSM
KODK
LPCN
MNKD
NBIX
NCLH
ONCY
ORIC
PBYI
PEGA
PLRX
PRGS
QGEN
RGNX
ROST
RYAAY
SNOW
SWKS
SYK
TGT
TRMB
TXG
ULTA
VRSK
WDC
WVE
XOM
ZBRA
ZNTL
ZTS
STOK
IONS
MOMO
BBAR
CTXR
MBIO
GNS
NEON
OVID
BHVN
Major Depressive Disorder Market is Predicted to Grow During the Forecast Period (2026-2036) as Novel Antidepressants are Expected to Enter the Market | DelveInsight
prnewswire.com
JNJ
XENE
LLY
ABBV
AXSM
ALTO
Form 8-K
sec.gov
XENE
Xenon Reports Q2 2026 Financial Results and Provides Business Update
globenewswire.com
XENE
Xenon Reports Q2 2026 Financial Results and Provides Business Update
globenewswire.com
XENE
F4 Begins Search for Radioactive Boulders at Todd and Wales Lake Ready to Announce with Confidence?
newsfilecorp.com
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XENE